These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 1715540)
1. Serotonergic involvement in the cardiovascular stimulation by thyrotropin-releasing hormone (TRH) in anesthetized rats. Nurminen ML; Paakkari I; Seppälä T Neurosci Lett; 1991 Jun; 127(2):147-9. PubMed ID: 1715540 [TBL] [Abstract][Full Text] [Related]
2. The effect of p-chloroamphetamine and p-chlorophenylalanine on the level of thyrotropin-releasing hormone and its receptors in some brain structures and lumbar spinal cord of the rat. Przegaliński E; Jaworska L; Gołembiowska K Neuropeptides; 1992 Sep; 23(1):19-25. PubMed ID: 1383865 [TBL] [Abstract][Full Text] [Related]
3. Role of peripheral and central catecholaminergic and cholinergic mechanisms in the cardiovascular effects of thyrotropin-releasing hormone. Nurminen ML; Paakkari I Neuropeptides; 1991 Dec; 20(4):247-53. PubMed ID: 1667428 [TBL] [Abstract][Full Text] [Related]
4. Effect of p-chlorophenylalanine at moderate dosage on 5-HT and 5-HIAA concentrations in brain regions of control and p-chloroamphetamine treated rats. Datla KP; Curzon G Neuropharmacology; 1996 Mar; 35(3):315-20. PubMed ID: 8783206 [TBL] [Abstract][Full Text] [Related]
5. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment. Dewar KM; Grondin L; Carli M; Lima L; Reader TA J Neurochem; 1992 Jan; 58(1):250-7. PubMed ID: 1370077 [TBL] [Abstract][Full Text] [Related]
6. Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord. Sharif NA; Towle AC; Burt DR; Mueller RA; Breese GR Brain Res; 1989 Feb; 480(1-2):365-71. PubMed ID: 2540880 [TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat. Curzon G; Fernando JC; Marsden CA Br J Pharmacol; 1978 Aug; 63(4):627-34. PubMed ID: 80243 [TBL] [Abstract][Full Text] [Related]
8. Dissociation of the cardiovascular and prolactin-releasing activities of norvaline2-TRH. Labroo VM; Cohen LA; Lozovsky D; Siren AL; Feuerstein G Neuropeptides; 1987 Jul; 10(1):29-36. PubMed ID: 3118236 [TBL] [Abstract][Full Text] [Related]
9. Effects of serotonergic system on hypothalamic-pituitary-thyroid axis in rats. Mitsuma T; Nogimori T Horm Metab Res; 1983 Jul; 15(7):346-9. PubMed ID: 6224727 [TBL] [Abstract][Full Text] [Related]
10. The effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine on thyrotrophin-releasing hormone in regions of the brain and spinal cord of the rat. Lighton C; Marsden CA; Bennett GW Neuropharmacology; 1984 Jan; 23(1):55-60. PubMed ID: 6232468 [TBL] [Abstract][Full Text] [Related]
11. Pressor and sympathetic responses to dorsal raphe nucleus infusions of TRH in rats. Mattila J; Buñag RD Am J Physiol; 1990 Jun; 258(6 Pt 2):R1464-71. PubMed ID: 2113776 [TBL] [Abstract][Full Text] [Related]
12. Effect of thyrotropin releasing hormone and some of its histidine analogs on the cardiovascular system and prolactin release in the conscious rat. Siren AL; Feuerstein G; Labroo VM; Cohen LA; Lozovsky D Neuropeptides; 1986 Jul; 8(1):63-70. PubMed ID: 3093911 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of p-chlorophenylalanine on indoleamines in brainstem nuclei and spinal cord of rats. I. Biochemical and behavioral analysis. Steinman JL; Carlton SM; Haber B; Willis WD Brain Res; 1987 Nov; 426(2):297-309. PubMed ID: 2446710 [TBL] [Abstract][Full Text] [Related]
14. The involvement of central cholinergic mechanisms in cardiovascular responses to intracerebroventricular and intravenous administration of thyrotropin-releasing hormone. Okuda C; Mizobe T; Miyazaki M Life Sci; 1987 Mar; 40(13):1293-9. PubMed ID: 3104710 [TBL] [Abstract][Full Text] [Related]
15. Thyrotropin releasing hormone potentiates the effects of imipramine on brain serotonergic system. Rastogi RB; Singhal RL; Lapierre YD Brain Res Bull; 1981 Oct; 7(4):449-51. PubMed ID: 6170395 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a role of brain serotonergic neurotransmission in avoidance learning. Ogren SO Acta Physiol Scand Suppl; 1985; 544():1-71. PubMed ID: 3006431 [TBL] [Abstract][Full Text] [Related]
17. Depletion of serotonin using p-chlorophenylalanine (PCPA) and reserpine protects against the neurotoxic effects of p-chloroamphetamine (PCA) in the brain. Berger UV; Grzanna R; Molliver ME Exp Neurol; 1989 Feb; 103(2):111-5. PubMed ID: 2521470 [TBL] [Abstract][Full Text] [Related]
18. Perturbation of rat brain serotonergic systems results in an inverse relation between substance P and serotonin concentrations measured in discrete nuclei. Barden N; Daigle M; Picard V; Di Paolo T J Neurochem; 1983 Sep; 41(3):834-40. PubMed ID: 6192216 [TBL] [Abstract][Full Text] [Related]
19. Effect of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin secretion in the serotonin-blocked, estrogen-treated ovariectomized rats. Pan JT; Wang PS Neuroendocrinology; 1989 Mar; 49(3):281-5. PubMed ID: 2524012 [TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effect of intravenously administered thyrotropin-releasing hormone and its concentration in push-pull perfusion of the fourth ventricle in conscious and pentobarbital-anesthetized rats. Okuda C; Tanaka H; Miyazaki M Life Sci; 1988; 42(11):1181-8. PubMed ID: 3126373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]